MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2023 International Congress

    An investigation of early changes in the brain due to mild cognitive impairment in Parkinson’s disease

    N. Saadat, E. Mazerolle, J. Gawryluk (Victoria, Canada)

    Objective: To identify baseline structural brain differences between individuals with Parkinson's disease (PD) who go on to develop mild cognitive impairment (PD-MCI) and those who…
  • 2023 International Congress

    London-Dhaka Parkinson’s Cognition Study: A collaboration to evaluate cognitive impairment in under-represented Parkinson’s disease patients

    T. Zannat, K. Dey, A. Zirra, A. Haque, E. Camboe, T. Haque, S. Waters, D. Mair, C. Marshall, A. Noyce, A. Habib (Dhaka, Bangladesh)

    Objective: Our aim is to study the prevalence of cognitive impairment (CI) in a diverse group of people with Parkinson's disease (PwP) from East London,…
  • 2023 International Congress

    cerebellar cognitive affective syndrome is frequent in rfc1-related disorder

    C. Lobo, NB. Santos, F. Lima, T. Rezende, PC. Matos, JL. Pedroso, O. Barsottini, W. Marques Jr, M. França Jr (Campinas, Brazil)

    Objective: To describe the prevalence and clinical profile of cerebellar cognitive affective syndrome (CCAS) in patients with RFC1-related disorder. Background: Since the recent description of…
  • 2023 International Congress

    Longitudinal association of mild behavioral impairment with cognitive decline in Parkinson’s disease

    G. Pinilla-Monsalve, M. Kibreab, N. Maarouf, I. Kathol, Z. Ismail, O. Monchi (Montréal, Canada)

    Objective: To analyze the cross-sectional and longitudinal association between mild behavioral impairment and cognitive impairment in Parkinson’s disease. Background: Cognitive impairment and neuropsychiatric symptoms (NPS)…
  • 2023 International Congress

    Muscle functions on the movement timings and inhibition in Parkinson’s disease.

    H. Singh, K S. Anand (Mysore, India)

    Objective: To assess the role of muscle strength, muscle tone and reflexes on the movement timings and inhibitory control in the subjects of Parkinson’s disease…
  • 2023 International Congress

    Leveraging MRI and machine-learning for early detection of cognitive impairment in Parkinson’s disease

    L. Saadatpour, A. Vijayakumari, B. Walter, H. Fernandez (Cleveland, USA)

    Objective: To develop a machine learning model using MRI data that predicts the likelihood of cognitive impairment in newly diagnosed patients with Parkinson's disease (PD).…
  • 2023 International Congress

    Changes in artistic style and Parkinson’s Disease

    AM. Diezma Martín, G. Tabar Comellas, MI. Morales-Casado, DD. Garcia Melendez, JW. Ruiz Gómez, P. Quintana Castro, M. Ennazeh Elkhaili, D. Rivero Rodríguez, N. López Ariztegui (Toledo, Spain)

    Objective: We present a Parkinson’s disease (PD) patient in whom dopamine agonists produced a dramatic change in her art style and production, and the subsequent…
  • 2023 International Congress

    Abnormal sense of agency is involved in myoclonus dystonia phenotype through a cerebellar impairment

    C. Tarrano, C. Gallea, M. Vidailhet, E. Roze, Y. Worbe (Paris, France)

    Objective: To investigate the sense of agency in patients with myoclonus-dystonia (DYT-SGCE) compared to healthy volunteers (HV). Background: Sense of agency is an action-related cognitive…
  • 2023 International Congress

    Impact of orthostatic hypotension with sleep disturbance on cognition

    A. Ovchynnykova, E. Trufanov (Kyiv, Ukraine)

    Objective: To define features of cognitive decline in a group of patients with orthostatic hypotension combined with sleep disorders. Background: recent data suggest that orthostatic…
  • 2023 International Congress

    Neuropsychological Outcomes After Bilateral Focused Ultrasound Thalamotomy within Essential Tremor

    M. Obolsky, N. Amitrano, N. Patel, S. Sani, M. Afshari, M. Wodziak, B. Bernard, S. Anderson, D. Gonzalez (Chicago, USA)

    Objective: The objective of the study was to elucidate the neuropsychological outcomes in executive functioning for patients with essential tremor undergoing bilateral MRI guided Focused…
  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley